A study on the compliance with patient expectation of selected drugs data in official websites of pharmaceutical companies: Opinions of medical and pharmacology students at Tehran University of Medical Sciences, Iran
Abstract
Background: Information technology has been developed so rapidly and pharmaceutical companies design websites with the goal of providing better service to customers and sell more products. The evaluation of information contained on the selected pharmaceutical company’s web sites is adapted in the current study to understand the needs and expectations of consumers.Methods: According to the research plan, a questionnaire used in a similar study by Walter Wymer was applied in this study. The reliability of the survey was confirmed by examining 12 primary samples through Cronbach’s alpha. Based on the statistical community of medical and pharmacy students that reside in the Tehran Medical Sciences University, Iran , the samples randomly were chosen. A total of 5 branded prescription drugs were selected either because they were evaluated as being poor consumer choices for safety reasons or better alteration exists. The study participants visited each of five websites for the selected drugs, and then they answered a series of questions for each website, to evaluate each website’s information content. Data were analyzed using SPSS software.Results: The results showed that only 2 of 5 websites was fully presenting benefit and risk information, predominantly the later one, and the limitations to the uses of drug. Pricing information, alternative medicines, treatments, and behavioral approaches for dealing with an illness or health condition were not part of the information provided by drug companies.Conclusion: Only two of the five selected web sites had relatively good condition. Hence, Iranian consumers need to be aware and careful to use the pharmaceutical company websites as a source of information for finding prescription drugs information.(1) Hashemian A. attar and atari up to employment of the first european pharmacists. Ganjine-Ye Asnad 2004; 14(55): 27-35. [In Persian].
(2) Sanaei A, Alavishad A. Internet marketing and its role in the development of the pharmaceutical industry's exports. Proceedings of the 3rd International Management Conference; 2006 Feb 13-14; Tehran, Iran. [In Persian].
(3) Fayaz-Bakhsh A, Khezri S. The impact of computerized physician order entry on medication error prevention. Int J Clin Pharm 2014; 36(6): 1097-8.
(4) Kalantari E, Fayaz-Bakhsh A. Can an electronic prescribing system detect doctors who are more likely to make a serious prescribing error? J R Soc Med 2012; 105(5): 191.
(5) Neishaboori Gh. Per capita drug consumption in Iran is three times more than the international standards [Online]. [cited 2015 Apr 9]; Available from: URL: http://donya-e-eqtesad.com/news/871202 [In Persian].
(6) Kaushal R, Bates DW. Information technology and medication safety: what is the benefit? Qual Saf Health Care 2002; 11(3): 261-5.
(7) Sauerwald PL. Changing the Channel: Developments in US Specialty Pharmaceutical Distribution [Online]. [cited 2009 Oct 10]; Available from: URL:
http://pharmaceuticalcommerce.com/business-and-finance/changing-the-channel-developments-in-us-specialty-pharmaceutical-distribution/ [In Persian].
(8) Drucker PF. The effective executive. New York, NY: Harper & Row; 1967.
(9) Zaiane OR. Building virtual web views. Data Knowl Eng 2001; 39(2): 143-63.
(10) Alperstein NM, Peyrot M. Consumer awareness of prescription drug advertising. J Advert Res 1970; 33(4): 50-6.
(11) Gellad ZF, Lyles KW. Direct-to-consumer advertising of pharmaceuticals. Am J Med 2007; 120(6): 475-80.
(12) Blank C. Pharmaceutical Marketing Shifts Online [Online]. [cited 2006 Jun 1]; Available from: URL: http://www.dmnews.com/news/pharmaceutical-marketing-shifts-online/article/91390/
(13) Wymer W. Consumer perceptions of prescription drug websites: A pilot study. Health Mark Q 2010; 27(2): 173-94.
(14) Menon AM, Deshpande AD, Perri M, III, Zinkhan GM. Trust in online prescription drug information among internet users: the impact on information search behavior after exposure to direct-to-consumer advertising. Health Mark Q 2002; 20(1): 17-35.
(15) Macias W, Stavchansky LL. How well do direct-to-consumer, DTC, prescription drug web sites meet FDA guidelines and public policy concerns? Health Mark Q 2005; 22(4): 45-71.
(16) Calfee JE. Public policy issues in direct-to-consumer advertising of prescription drugs. j public policy mark 2002; 21(2): 174-93.
(17) Darabpoor M. Substantive review of consumer rights protection law in the UK and the need to reform their deficiencies in Iranian Law. Law Res Mag 2008; (48): 9-63. [In Persian].
(18) Hossini M. Observing consumers' rights in pharmaceutical and cosmetics advertising and marketing. Iran J Med Ethics Hist Med 2009; 3(1): 33-42. [In Persian].
(19) Sheehan B. In Poor Health: An assessment of privacy policies at direct-to-consumer web sites. J Public Policy Mark 2005; 24(2): 273-83.
(20) Woloshin S, Schwartz LM, Tremmel J, Welch HG. Direct-to-consumer advertisements for prescription drugs: what are Americans being sold? Lancet 2001; 358(9288): 1141-6.
(21) Huntington P, Nicholas D, Jamali HR. Website usage metrics: A re-assessment of session data. Inform Process Manag 2008; 44(1): 358-72
| Files | ||
| Issue | Vol 2 No 1/2 (2016) | |
| Section | Original Article(s) | |
| Keywords | ||
| Drug advertising Prescription drug websites Pharmaceutical marketing Consumer’s rights | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
